| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |





From the Renal and Vascular Laboratory,*
Fundación
Jiménez Díaz, Autonoma University, Madrid, Spain; the
Departments of Internal Medicine
and
Pathology,
Hospital Clinico, Complutense
University, Madrid, Spain; and the Discovery Research
Laboratory,
Tanabe Seiyaku Company, Limited,
Osaka, Japan
Using angiotensin II (AngII) type 1A receptor-deficient mice
[AT1(-/-)], in which we induced protein overload
nephropathy, we explored the potential implication of AngII and
endothelin-1 (ET-1) in the tubulointerstitial damage because of
persistent proteinuria. At day 7, AT1(-/-) showed marked
proteinuria to a similar extent to that of wild-type mice (WT).
However, at day14, AT1(-/-) had significantly less
proteinuria, renal damage, transforming growth
factor-ß, and matrix mRNA expression and mortality.
AT1(-/-) also showed a significant diminution in the activation of
the transcriptional factors nuclear factor-
B and AP-1.
Unexpectedly, AT1(-/-) had a higher interstitial infiltration
than WT. The administration of the angiotensin-converting enzyme
inhibitor quinapril to WT caused a marked improvement in proteinuria
and renal lesions, resembling that seen in untreated
AT1(-/-). However, the interstitial infiltration persisted in
AT1(-/-) when treated with quinapril. Because ET-1 may participate in
the recruitment of mononuclear cells, we also studied the
implication of this peptide. AT1(-/-) had a significantly higher ET-1
expression in tubular epithelial cells than WT. The administration of
the dual ETA/ETB antagonist bosentan to AT1(-/-) considerably reduced
the interstitial infiltrates. Bosentan also exerted a beneficial effect
on proteinuria, renal lesions, and mortality in WT.
These data show that in overload nephropathy, proteinuria and
renal lesions are, to a large extent, AngII-dependent.
The up-regulation of ET-1 in tubular epithelial cells in
AT1(-/-), associated with interstitial infiltrates,
suggests that the combination of drugs interfering with both
vasopeptides may be of therapeutic interest in renal diseases with
severe proteinuria and tubulointerstitial damage.
This article has been cited by other articles:
![]() |
Y. Kamijo, K. Hora, K. Kono, K. Takahashi, M. Higuchi, T. Ehara, K. Kiyosawa, H. Shigematsu, F. J. Gonzalez, and T. Aoyama PPAR{alpha} Protects Proximal Tubular Cells from Acute Fatty Acid Toxicity J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3089 - 3100. [Full Text] [PDF] |
||||
![]() |
Y. C. Chan and P. S. Leung Angiotensin II Type 1 Receptor-Dependent Nuclear Factor-{kappa}B Activation-Mediated Proinflammatory Actions in a Rat Model of Obstructive Acute Pancreatitis J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 10 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Saez, M. T. Castells, A. Zuasti, F. Salazar, V. Reverte, A. Loria, and F. J. Salazar Sex Differences in the Renal Changes Elicited by Angiotensin II Blockade During the Nephrogenic Period Hypertension, June 1, 2007; 49(6): 1429 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okada, T. Inoue, T. Kikuta, Y. Watanabe, Y. Kanno, S. Ban, T. Sugaya, M. Horiuchi, and H. Suzuki A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade Am. J. Pathol., November 1, 2006; 169(5): 1577 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dalbeth, J. Edwards, S. Fairchild, M. Callan, and F. C. Hall The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis Rheumatology, January 1, 2005; 44(1): 24 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Benigni, D. Corna, C. Zoja, L. Longaretti, E. Gagliardini, N. Perico, T. M. Coffman, and G. Remuzzi Targeted Deletion of Angiotensin II Type 1A Receptor Does not Protect Mice from Progressive Nephropathy of Overload Proteinuria J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2666 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamijo, T. Sugaya, A. Hikawa, M. Okada, F. Okumura, M. Yamanouchi, A. Honda, M. Okabe, T. Fujino, Y. Hirata, et al. Urinary Excretion of Fatty Acid-Binding Protein Reflects Stress Overload on the Proximal Tubules Am. J. Pathol., October 1, 2004; 165(4): 1243 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Esteban, O. Lorenzo, M. Ruperez, Y. Suzuki, S. Mezzano, J. Blanco, M. Kretzler, T. Sugaya, J. Egido, and M. Ruiz-Ortega Angiotensin II, via AT1 and AT2 Receptors and NF-{kappa}B Pathway, Regulates the Inflammatory Response in Unilateral Ureteral Obstruction J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1514 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tejera, D. Gomez-Garre, A. Lazaro, J. Gallego-Delgado, C. Alonso, J. Blanco, A. Ortiz, and J. Egido Persistent Proteinuria Up-Regulates Angiotensin II Type 2 Receptor and Induces Apoptosis in Proximal Tubular Cells Am. J. Pathol., May 1, 2004; 164(5): 1817 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Suzuki, M. Ruiz-Ortega, C. Gomez-Guerrero, Y. Tomino, and J. Egido Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1423 - 1426. [Full Text] [PDF] |
||||
![]() |
Y. Suzuki, M. Ruiz-Ortega, C. Gomez-Guerrero, Y. Tomino, and J. Egido Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1423 - 1426. [Full Text] |
||||
![]() |
Y. Suzuki, C. Gomez-Guerrero, I. Shirato, O. Lopez-Franco, J. Gallego-Delgado, G. Sanjuan, A. Lazaro, P. Hernandez-Vargas, K. Okumura, Y. Tomino, et al. Pre-Existing Glomerular Immune Complexes Induce Polymorphonuclear Cell Recruitment Through an Fc Receptor-Dependent Respiratory Burst: Potential Role in the Perpetuation of Immune Nephritis J. Immunol., March 15, 2003; 170(6): 3243 - 3253. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |